|
PRESS RELEASE
February 2005
NEW
DEAL BRINGS RAPID TB TEST TO GLOBAL MARKETS
Rapid Biosensor
Systems and Clement Clarke International agree manufacturing and
sales partnership
Rapid Biosensor
Systems (RBS), the Cambridge-based developer of rapid sensor solutions
for the detection of infectious diseases, has agreed a business
venturing partnership with Clement Clarke International (CCI) of
Harlow, UK. CCI will exclusively manufacture and distribute RBS's
TB breathalyser - a device that can detect the presence of TB in
less than 5 minutes.
TB, a respiratory
disease, kills some two million people every year and is on the
increase not only in developing countries but also in first world
regions. Recent UK news bulletins have highlighted the need for
rapid and effective tests to enable speedy treatment and to stop
the spread of this highly infectious disease.
CCI has proven
its dedication to research and development in anticipation of market
changes since its formation in 1917 with a series of firsts within
asthma management, telecommunications and ophthalmic instrumentation.
As one of the Haag-Streit Group companies for the last 15 years,
CCI has focused on developing and acquiring the highest quality
products to strengthen its respiratory portfolio.
RBS CEO Dennis
Camilleri said, ' we have been seeking a Partner with world-class
manufacturing facilities and established global sales channels for
medical devices. We are delighted and excited about working with
CCI as they will provide resources and considerable experience to
reach all those that will benefit from this new test'.
CCI Managing
Director Brian Woodcock said, ' CCI is continuously evaluating technologies
for new business opportunities. The RBS TB breathalyser is a truly
innovative product that fits strategically within our product portfolio
and business growth targets'.
The partnership
allows RBS to retain all its Intellectual Property Rights and to
collaborate with other organisations on new sensor applications.
RBS is also working with Universities and other opinion leaders
to develop new technological applications which would further enhance
the current product portfolio.
ENDS
Further information:
Dennis Camilleri, RBS Ltd Tel: +441223 264558, Mobile: 07980 980047
email: dennis.camilleri@rapidbiosensor.com
Brian Woodcock,
Clement Clarke International Ltd Tel: +44 1279 414969
bdw@clement-clarke.com
Photo available
on request
|